Xeris Biopharma Holdings, Inc. (XERS) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$14,914
Total Return
49.14%
CAGR
8.32%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.45% |
| Median | +2.34% |
| Best | +82.31% |
| Worst | -42.54% |
| % of Windows Positive | 54.0% |
1-Year (252 Trading Days)
| Average | +43.30% |
| Median | +34.12% |
| Best | +238.03% |
| Worst | -66.53% |
| % of Windows Positive | 64.8% |
3-Year (756 Trading Days)
| Average | +178.21% |
| Median | +92.05% |
| Best | +656.91% |
| Worst | -56.90% |
| % of Windows Positive | 82.4% |
Risk Metrics
| Maximum Drawdown | -78.59% |
| Average Drawdown | -43.33% |
| Drawdown Duration | 932 Trading Days |
| Sortino Ratio | 0.73 |
| Calmar Ratio | 0.11 |
| CVaR (5%) | -8.41% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -22.68% (-59.47% ann.) | $2267.50 | $0.00 | $0.00 | $0.00 |
| 2025 | +131.56% | +$13156.28 | $0.00 | $0.00 | $0.00 |
| 2024 | +44.25% | +$4425.50 | $0.00 | $0.00 | $0.00 |
| 2023 | +76.69% | +$7669.36 | $0.00 | $0.00 | $0.00 |
| 2022 | -54.61% | $5460.78 | $0.00 | $0.00 | $0.00 |
| 2021 | -40.45% | $4044.71 | $0.00 | $0.00 | $0.00 |
| 2020 | -30.21% | $3021.30 | $0.00 | $0.00 | $0.00 |
| 2019 | -58.53% | $5852.94 | $0.00 | $0.00 | $0.00 |
| 2018 partial | -15.92% (-27.98% ann.) | $1592.48 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | June 21, 2018 – February 19, 2020 | -76.71% | -58.32% | $7670.62 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -64.01% | -100.00% | $6400.89 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +172.50% | +401.78% | +$17249.98 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -64.46% | -62.52% | $6446.00 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -29.19% | -30.68% | $2918.65 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +93.33% | +42.71% | +$9333.28 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +109.31% | +60.13% | +$10931.10 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.